Proactiveinvestors United Kingdom 01 Communique Laboratory https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom 01 Communique Laboratory RSS feed en Fri, 21 Feb 2020 06:27:01 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Hummingbird Resources’ Monro on new plan for Yanfolila mine https://www.proactiveinvestors.co.uk/companies/news/303865/hummingbird-resources-monro-on-new-plan-for-yanfolila-mine-3865.html Wed, 17 Jun 2015 14:10:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/303865/hummingbird-resources-monro-on-new-plan-for-yanfolila-mine-3865.html 01 Communique's stock plummets after patent suit verdict https://www.proactiveinvestors.co.uk/companies/news/101719/01-communiques-stock-plummets-after-patent-suit-verdict-54635.html Mon, 09 Jun 2014 18:24:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/101719/01-communiques-stock-plummets-after-patent-suit-verdict-54635.html Siga lands big contract for a smallpox antiviral, but rival protests https://www.proactiveinvestors.co.uk/companies/news/266945/siga-lands-big-contract-for-a-smallpox-antiviral-but-rival-protests-0276.html Mon, 16 May 2011 10:27:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266945/siga-lands-big-contract-for-a-smallpox-antiviral-but-rival-protests-0276.html Oncosec Medical:One to watch https://www.proactiveinvestors.co.uk/companies/news/266944/oncosec-medicalone-to-watch-0275.html Fri, 13 May 2011 14:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266944/oncosec-medicalone-to-watch-0275.html Ovarian cancer blood test sends Vermillion rocketing. OXiGENE soars on leukemia trial start, first quarter profit sends Sunesis higher. https://www.proactiveinvestors.co.uk/companies/news/266943/ovarian-cancer-blood-test-sends-vermillion-rocketing-oxigene-soars-on-leukemia-trial-start-first-quarter-profit-sends-sunesis-higher-0274.html Fri, 13 May 2011 08:41:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266943/ovarian-cancer-blood-test-sends-vermillion-rocketing-oxigene-soars-on-leukemia-trial-start-first-quarter-profit-sends-sunesis-higher-0274.html eResearch places "speculative buy" and $1.90 price target on Leader Energy Services https://www.proactiveinvestors.co.uk/companies/news/266942/eresearch-places-speculative-buy-and-190-price-target-on-leader-energy-services-0273.html Thu, 12 May 2011 12:47:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266942/eresearch-places-speculative-buy-and-190-price-target-on-leader-energy-services-0273.html Allos earnings disappoint, Halozyme jumps on licensing deal with ViroPharma https://www.proactiveinvestors.co.uk/companies/news/266940/allos-earnings-disappoint-halozyme-jumps-on-licensing-deal-with-viropharma-0271.html Thu, 12 May 2011 08:52:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266940/allos-earnings-disappoint-halozyme-jumps-on-licensing-deal-with-viropharma-0271.html Shortage of Radioisotopes Threatens Medical Research and Treatment https://www.proactiveinvestors.co.uk/companies/news/266939/shortage-of-radioisotopes-threatens-medical-research-and-treatment--0270.html Thu, 12 May 2011 08:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266939/shortage-of-radioisotopes-threatens-medical-research-and-treatment--0270.html OncoVista (OTC:OVIT) positioning itself for the next level https://www.proactiveinvestors.co.uk/companies/news/266937/oncovista-otcovit-positioning-itself-for-the-next-level-0268.html Wed, 11 May 2011 13:41:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266937/oncovista-otcovit-positioning-itself-for-the-next-level-0268.html US consumer group alleges that researchers with ties to Eli Lilly withheld information about drug for Alzheimer's https://www.proactiveinvestors.co.uk/companies/news/266936/us-consumer-group-alleges-that-researchers-with-ties-to-eli-lilly-withheld-information-about-drug-for-alzheimers-0267.html Wed, 11 May 2011 09:37:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266936/us-consumer-group-alleges-that-researchers-with-ties-to-eli-lilly-withheld-information-about-drug-for-alzheimers-0267.html Incyte or YM Biosciences - which JAK to choose? https://www.proactiveinvestors.co.uk/companies/news/266935/incyte-or-ym-biosciences-which-jak-to-choose-0266.html Tue, 10 May 2011 15:16:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266935/incyte-or-ym-biosciences-which-jak-to-choose-0266.html Exelixis and Ariad Pharmaceuticals set to shine at ASCO 2011 https://www.proactiveinvestors.co.uk/companies/news/266933/exelixis-and-ariad-pharmaceuticals-set-to-shine-at-asco-2011-0264.html Mon, 09 May 2011 12:07:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266933/exelixis-and-ariad-pharmaceuticals-set-to-shine-at-asco-2011-0264.html PerkinElmer tops higher-than-expected profit. Kendle acquired, shares soar. https://www.proactiveinvestors.co.uk/companies/news/266932/perkinelmer-tops-higher-than-expected-profit-kendle-acquired-shares-soar-0263.html Fri, 06 May 2011 13:16:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266932/perkinelmer-tops-higher-than-expected-profit-kendle-acquired-shares-soar-0263.html Rexahn says two-thirds of total patients now enrolled in clinical trial https://www.proactiveinvestors.co.uk/companies/news/266929/rexahn-says-two-thirds-of-total-patients-now-enrolled-in-clinical-trial--0260.html Thu, 05 May 2011 12:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266929/rexahn-says-two-thirds-of-total-patients-now-enrolled-in-clinical-trial--0260.html ARCA scores with Novartis deal, Incyte rallies on strong earnings report https://www.proactiveinvestors.co.uk/companies/news/266925/-arca-scores-with-novartis-deal-incyte-rallies-on-strong-earnings-report-0256.html Wed, 04 May 2011 07:48:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266925/-arca-scores-with-novartis-deal-incyte-rallies-on-strong-earnings-report-0256.html Swiss Investors Going Direct: family offices and high net worth investors avoiding funds https://www.proactiveinvestors.co.uk/companies/news/266924/swiss-investors-going-direct-family-offices-and-high-net-worth-investors-avoiding-funds-0255.html Wed, 04 May 2011 07:42:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266924/swiss-investors-going-direct-family-offices-and-high-net-worth-investors-avoiding-funds-0255.html Northwest Biotherapeutics recruits for clinical trial of brain cancer therapy https://www.proactiveinvestors.co.uk/companies/news/266923/northwest-biotherapeutics-recruits-for-clinical-trial-of-brain-cancer-therapy-0254.html Tue, 03 May 2011 09:39:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266923/northwest-biotherapeutics-recruits-for-clinical-trial-of-brain-cancer-therapy-0254.html Intellipharmaceutics making news with FDA and CNN spotlight https://www.proactiveinvestors.co.uk/companies/news/266922/intellipharmaceutics-making-news-with-fda-and-cnn-spotlight-0253.html Tue, 03 May 2011 09:34:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266922/intellipharmaceutics-making-news-with-fda-and-cnn-spotlight-0253.html CPM Group warns that silver prices are "extremely vulnerable to a sharp decline" https://www.proactiveinvestors.co.uk/companies/news/266921/cpm-group-warns-that-silver-prices-are-extremely-vulnerable-to-a-sharp-decline--0252.html Tue, 03 May 2011 09:29:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266921/cpm-group-warns-that-silver-prices-are-extremely-vulnerable-to-a-sharp-decline--0252.html Allos Therapeutics shows near and long term potential https://www.proactiveinvestors.co.uk/companies/news/266920/allos-therapeutics-shows-near-and-long-term-potential-0251.html Mon, 02 May 2011 16:54:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266920/allos-therapeutics-shows-near-and-long-term-potential-0251.html Teva snaps up Cephalon for US$7 billion https://www.proactiveinvestors.co.uk/companies/news/266919/teva-snaps-up-cephalon-for-us7-billion-0250.html Mon, 02 May 2011 16:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266919/teva-snaps-up-cephalon-for-us7-billion-0250.html Morales annuls mining, banking and investment laws in Bolivia https://www.proactiveinvestors.co.uk/companies/news/266918/morales-annuls-mining-banking-and-investment-laws-in-bolivia-0249.html Mon, 02 May 2011 11:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266918/morales-annuls-mining-banking-and-investment-laws-in-bolivia-0249.html AVEA’s shares jump on strong revenues, CytRx secures Orphan Drug designation, FDA panel backs Vertex Hep C drug https://www.proactiveinvestors.co.uk/companies/news/266917/aveas-shares-jump-on-strong-revenues-cytrx-secures-orphan-drug-designation-fda-panel-backs-vertex-hep-c-drug-0248.html Fri, 29 Apr 2011 07:36:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266917/aveas-shares-jump-on-strong-revenues-cytrx-secures-orphan-drug-designation-fda-panel-backs-vertex-hep-c-drug-0248.html Regeneron soars on analyst upgrade, Spectrum moves on strong revenues, Radient surges higher on trial results https://www.proactiveinvestors.co.uk/companies/news/266916/regeneron-soars-on-analyst-upgrade-spectrum-moves-on-strong-revenues-radient-surges-higher-on-trial-results-0247.html Thu, 28 Apr 2011 15:04:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266916/regeneron-soars-on-analyst-upgrade-spectrum-moves-on-strong-revenues-radient-surges-higher-on-trial-results-0247.html Copper could re-test previous record high - Scotiabank https://www.proactiveinvestors.co.uk/companies/news/266915/copper-could-re-test-previous-record-high-scotiabank-0246.html Thu, 28 Apr 2011 14:57:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266915/copper-could-re-test-previous-record-high-scotiabank-0246.html Reasons to be optimistic about Acaida Pharmaceuticals https://www.proactiveinvestors.co.uk/companies/news/266914/reasons-to-be-optimistic-about-acaida-pharmaceuticals-0245.html Wed, 27 Apr 2011 08:29:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266914/reasons-to-be-optimistic-about-acaida-pharmaceuticals-0245.html OneMedForum NY 2011 Grows Its Advisory Board And Selects Initial Presenters https://www.proactiveinvestors.co.uk/companies/news/266913/onemedforum-ny-2011-grows-its-advisory-board-and-selects-initial-presenters-0244.html Tue, 19 Apr 2011 09:25:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266913/onemedforum-ny-2011-grows-its-advisory-board-and-selects-initial-presenters-0244.html Lack of Antibiotics for Drug Resistant Bacteria- Real Or Hype? https://www.proactiveinvestors.co.uk/companies/news/266912/lack-of-antibiotics-for-drug-resistant-bacteria-real-or-hype-0243.html Mon, 18 Apr 2011 15:05:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266912/lack-of-antibiotics-for-drug-resistant-bacteria-real-or-hype-0243.html Biotech stocks to watch: Amarin, Corcept, Exelixis, Vertex, Optimer, Onyx and AVEO https://www.proactiveinvestors.co.uk/companies/news/266911/biotech-stocks-to-watch-amarin-corcept-exelixis-vertex-optimer-onyx-and-aveo-0242.html Thu, 14 Apr 2011 16:26:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266911/biotech-stocks-to-watch-amarin-corcept-exelixis-vertex-optimer-onyx-and-aveo-0242.html Is Europe a better place to build a medical technology company? https://www.proactiveinvestors.co.uk/companies/news/266910/is-europe-a-better-place-to-build-a-medical-technology-company-0241.html Wed, 13 Apr 2011 15:18:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266910/is-europe-a-better-place-to-build-a-medical-technology-company-0241.html Canada Lithium faces class action over Quebec project resources estimate https://www.proactiveinvestors.co.uk/companies/news/266909/canada-lithium-faces-class-action-over-quebec-project-resources-estimate-0240.html Tue, 12 Apr 2011 15:07:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266909/canada-lithium-faces-class-action-over-quebec-project-resources-estimate-0240.html Molycorp and Department of Energy may help re-energize U.S. rare earth science https://www.proactiveinvestors.co.uk/companies/news/266908/molycorp-and-department-of-energy-may-help-re-energize-us-rare-earth-science-0239.html Fri, 01 Apr 2011 09:07:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266908/molycorp-and-department-of-energy-may-help-re-energize-us-rare-earth-science-0239.html HudBay's copper equivalent reserves surge 288% https://www.proactiveinvestors.co.uk/companies/news/266907/hudbays-copper-equivalent-reserves-surge-288-0238.html Fri, 01 Apr 2011 09:03:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266907/hudbays-copper-equivalent-reserves-surge-288-0238.html eResearch Stock of the Week: Innovente Inc https://www.proactiveinvestors.co.uk/companies/news/266906/eresearch-stock-of-the-week-innovente-inc-0237.html Tue, 29 Mar 2011 15:09:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266906/eresearch-stock-of-the-week-innovente-inc-0237.html Cambridge House to host Calgary Resource Investment Conference April 9-10 https://www.proactiveinvestors.co.uk/companies/news/266905/-cambridge-house-to-host-calgary-resource-investment-conference-april-9-10-0236.html Mon, 28 Mar 2011 16:22:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266905/-cambridge-house-to-host-calgary-resource-investment-conference-april-9-10-0236.html Pozen Gets Social To Sell Drugs https://www.proactiveinvestors.co.uk/companies/news/266904/pozen-gets-social-to-sell-drugs-0235.html Thu, 24 Mar 2011 15:47:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/266904/pozen-gets-social-to-sell-drugs-0235.html Gilead Continues Move Into Oncology With Calistoga Acquisition https://www.proactiveinvestors.co.uk/companies/news/266903/gilead-continues-move-into-oncology-with-calistoga-acquisition-0234.html Wed, 09 Mar 2011 08:59:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/266903/gilead-continues-move-into-oncology-with-calistoga-acquisition-0234.html GSK Pursues Fabry Disease Drug as Orphan Indications Are All The Rage https://www.proactiveinvestors.co.uk/companies/news/266902/gsk-pursues-fabry-disease-drug-as-orphan-indications-are-all-the-rage--0233.html Fri, 18 Feb 2011 14:36:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/266902/gsk-pursues-fabry-disease-drug-as-orphan-indications-are-all-the-rage--0233.html Eli Lilly: Plenty Of Talk, Now Time For Results https://www.proactiveinvestors.co.uk/companies/news/266901/eli-lilly-plenty-of-talk-now-time-for-results-0232.html Fri, 18 Feb 2011 10:28:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/266901/eli-lilly-plenty-of-talk-now-time-for-results-0232.html Zack's Daily Bull and Bear Highlights Sara Lee, Stanley Black & Decker, Dean Foods, Air Products and Airgas, Inc https://www.proactiveinvestors.co.uk/companies/news/266900/zacks-daily-bull-and-bear-highlights-sara-lee-stanley-black-decker-dean-foods-air-products-and-airgas-inc-0231.html Thu, 17 Feb 2011 09:52:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/266900/zacks-daily-bull-and-bear-highlights-sara-lee-stanley-black-decker-dean-foods-air-products-and-airgas-inc-0231.html Obama Administration calls for 5% royalty on gross proceeds of mines https://www.proactiveinvestors.co.uk/companies/news/266899/obama-administration-calls-for-5-royalty-on-gross-proceeds-of-mines-0230.html Wed, 16 Feb 2011 19:37:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/266899/obama-administration-calls-for-5-royalty-on-gross-proceeds-of-mines-0230.html 01 Communique launches latest version of ‘I'm InTouch’ remote access software https://www.proactiveinvestors.co.uk/companies/news/70098/01-communique-launches-latest-version-of-im-intouch-remote-access-software-1200.html Tue, 31 Mar 2009 17:58:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/70098/01-communique-launches-latest-version-of-im-intouch-remote-access-software-1200.html